Autopsy report · NCT04907890

Long Term Outcomes in COVID-19 Patients Recruited in the CORIST Project

“Severe difficulties in enrolling individuals”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Sponsor

Neuromed IRCCS

Sponsor type

University, hospital or other

Conditions

Sars-CoV-2 Infection; Long Covid19

Participants

0

Sites

1

Countries

Italy

Trials that died the same way

• The Safety of Transdermal Nicotine Immediately Following an Acute Coronary Syndrome
  “Difficulties with enrollment.” (85% match in meaning)
• Multicentric Study Comparison Between Erythropoietin and Erythropoietin Associated to Differentiating Therapy With Acid 13-cis-retinoic and Dihydroxyvitamin D3 in Myelodysplastic Syndromes Without Excess of Blasts
  “Difficulties of enrollment” (85% match in meaning)
• Clinical Trial With Mesalamine 1g Suppositories
  “Enrollment difficulties” (84% match in meaning)
• Experience of Erlotinib in Patients With Advanced Non-Small Cell Lung Cancer
  “Difficulty in enrolling patients” (82% match in meaning)
• COPD Exacerbation Blood and Urine Biomarkers Study
  “Difficulty enrolling” (82% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.